Arbutus announces appointment of Daniel Burgess to board of directors
Arbutus announced the Company has appointed Daniel Burgess to the Board of Directors. Mr. Burgess has more than 25 years of executive level operating experience in biotech companies, including substantial experience in the anti-infective field. He is currently a Venture Partner at SV Life Sciences. March 23, 2017